References
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Health Disorders4th edWashington DCAmerican Psychiatric Association2000
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Health Disorders3rd edWashington, DCAmerican Psychiatric Association1980
- MageeWJEatonWWWittchenH-UMcGonagleKAKesslerRCAgoraphobia, simple phobia, and social phobia in the National Comorbidity SurveyArch Gen Psychiatry19965321591688629891
- RuscioABrownTChiuWSareenJSteinMKesslerRSocial fears and social phobia in the USA: results from the National Comorbidity Survey ReplicationPsychol Med2008381152817976249
- SteinMBKeanYMDisability and quality of life in social phobia: epidemiologic findingsAm J Psychiatry2000157101606161311007714
- KatzelnickDJKobakKADeLeireTImpact of generalized social anxiety disorder in managed careAm J Psychiatry2001158121999200711729016
- DavidsonJRHughesDGeorgeLKBlazerDGThe epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area StudyPsychol Med19932337097188234577
- DeWitDJOgborneAOffordDMacDonaldKAntecedents of the risk of recovery from DSM-III-R social phobiaPsychol Med199929356958210405078
- ChartierMJHazenALSteinMBLifetime patterns of social phobia: a retrospective study of the course of social phobia in a nonclinical populationDepress Anxiety1998731131219656091
- SchneierFRJohnsonJHornigCDLiebowitzMRWeissmanMMSocial phobia: comorbidity and morbidity in an epidemiologic sampleArch Gen Psychiatry19924942822881558462
- SchneierFRFooseTEHasinDSSocial anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related ConditionsPsychol Med201040697798820441690
- KesslerRCUstunTBThe WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental DisordersNew York, NYCambridge University Press2008
- SchneierFRPharmacotherapy of social anxiety disorderExpert Opin Pharmacother201112461562521241211
- RavindranLNSteinMBThe pharmacologic treatment of anxiety disorders: a review of progressJ Clin Psychiatry201071783985420667290
- AcarturkCCuijpersPvan StratenAde GraafRPsychological treatment of social anxiety disorder: a meta-analysisPsychol Med200939224125418507874
- PowersMBSigmarssonSEmmelkampPMGA meta-analytic review of psychological treatments for social anxiety disorderInt J Cogn Ther20081294113
- GanasenKIpserJSteinDAugmentation of cognitive behavioral therapy with pharmacotherapyPsychiatr Clin North Am201033368769920599140
- SteinDJBaldwinDSBandelowBA 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorderCurr Psychiatry Rep201012547147720686872
- GuyWECDEU Assessment Manual for Psychopharmacology – RevisedRockville, MDNational Institute of Mental Health1976
- BandelowBSeidler-BrandlerUBeckerAWedekindDRütherEMeta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disordersWorld J Biol Psychiatry20078317518717654408
- SteinDJIpserJvan BalkomAJPharmacotherapy for social anxiety disorderCochrane Database Syst Rev20004
- SteinMBLiebowitzMRLydiardRBPittsCDBushnellWGergelIParoxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trialJAMA199828087087139728642
- LiebowitzMRGelenbergAJMunjackDVenlafaxine extended release vs placebo and paroxetine in social anxiety disorderArch Gen Psychiatry2005a62219019815699296
- LiebowitzMRSteinMBTancerMCarpenterDOakesRPittsCDA randomized, double-blind, fixed-dose comparison of paroxetine and placebo in treatment of generalized social anxiety disorderJ Clin Psychiatry2002631667411838629
- LepolaUBergtholdtBSt LambertJDavyKLRuggieroLControlled-release paroxetine in the treatment of patients with social anxiety disorderJ Clin Psychiatry200465222222915003077
- LaderMStenderKBürgerVNilREfficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose studyDepress Anxiety200419424124815274173
- BaldwinDBobesJSteinDJScharwachterIFaureMParoxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study GroupBr J Psychiatry1999175212012610627793
- AllgulanderCManganoRZhangJEfficacy of venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetineHum Psychopharmacol200419638739615303242
- AllgulanderCParoxetine in social anxiety disorder: a randomized placebo-controlled studyActa Psychiatr Scand1999100319319810493085
- KasperSSteinDJLoftHNilREscitalopram in the treatment of social anxiety disorderBr J Psychiatry2005186322222615738503
- ZhangWConnorKMDavidsonJRTLevetiracetam in social phobia: a placebo controlled pilot studyJ Psychopharmacol200519555155316166192
- KobakKAGreistJHJeffersonJWKatzelnickDJFluoxetine in social phobia: a double-blind, placebo-controlled pilot studyJ Clin Psychopharmacol200222325726212006895
- DavidsonJRTFoaEBHuppertJDFluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobiaArch Gen Psychiatry2004a61101005101315466674
- van VlietIBoerJWestenbergHPsychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxaminePsychopharmacology199411511281347862884
- SteinMBFyerAJDavidsonJRPollackMHWiitaBFluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled studyAm J Psychiatry1999156575676010327910
- DavidsonJYaryura-TobiasJDuPontRFluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorderJ Clin Psychopharmacol2004b24211812515206657
- Van AmeringenMALaneRMWalkerJRSertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled studyAm J Psychiatry2001158227528111156811
- LiebowitzMRDeMartinisNAWeihsKEfficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled studyJ Clin Psychiatry200364778579212934979
- BlomhoffSHaugTTHellstromKRandomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobiaBr J Psychiatry20011791233011435264
- MontgomerySANilRDurr-PalNLoftHBoulengerJPA 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorderJ Clin Psychiatry200566101270127816259540
- SteinMBChartierMJHazenALParoxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuationJ Clin Psychopharmacol19961632182228784653
- SteinDJVersianiMHairTKumarREfficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week studyArch Gen Psychiatry200259121111111812470127
- WalkerJRVan AmeringenMASwinsonRPrevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatmentJ Clin Psychopharmacol200020663664411106135
- DonovanMRGluePKolluriSEmirBComparative efficacy of antidepressants in preventing relapse in anxiety disorders – a meta-analysisJ Affective Dis20101231916
- SimonNMWorthingtonJJMoshierSJGeneralized social anxiety disorder: a preliminary randomized trial of increased dose to optimize responseCNS Spectr2010157436443
- SteinMBPollackMHBystritskyAKelseyJEManganoRMEfficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trialPsychopharmacology2005177328028815258718
- RickelsKManganoRKhanAA double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorderJ Clin Psychopharmacol200424548849615349004
- LiebowitzMRManganoRMBradwejnJAsnisGSAD Study GroupA randomized controlled trial of venlafaxine extended release in generalized social anxiety disorderJ Clin Psychiatry2005b66223824715705011
- QuitkinFMStewartJWMcGrathPJTricamoEColumbia atypical depression: a subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placeboBr J Psychiatry1993163Suppl 213034
- VersianiMNardiAMundimFAlvesALiebowitzMAmreinRPharmacotherapy of social phobia. A controlled study with moclobemide and phenelzineBr J Psychiatry199216133533601393304
- LiebowitzMRSchneierFCampeasRPhenelzine vs atenolol in social phobia: A placebo-controlled comparisonArch Gen Psychiatry19924942903001558463
- HeimbergRGLiebowitzMRHopeDACognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcomeArch Gen Psychiatry19985512113311419862558
- GelernterCSUhdeTWCimbolicPCognitive-behavioral and pharmacological treatments of social phobia: a controlled studyArch Gen Psychiatry199148109389451929764
- VersianiMMundimFDNardiAELiebowitzMRTranylcypromine in social phobiaJ Clin Psychopharmacol1988842792833209719
- NuttDJGluePMonoamine oxidase inhibitors: rehabilitation from recent research?Br J Psychiatry19891542872912688773
- Van VlietIMden BoerJAWestenburgHGPsychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitorEur Neuropsychopharmacol19922121291638170
- LottMGreistJHJeffersonJWBrofaromine for social phobia: a multicenter, placebo-controlled, double-blind studyJ Clin Psychopharmacol19971742552609241003
- FahlénTNilssonHLBorgKHumbleMPauliUSocial phobia: the clinical efficacy and tolerability of the monoamine oxidase A and serotonin uptake inhibitor brofaromine: a double-blind placebo-controlled studyActa Psychiatr Scand19959253513588619339
- SteinDJCameronAAmreinRMoclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorderInt Clin Psychopharmacol200217416117012131599
- SchneierFRGoetzDCampeasRFallonBMarshallRLiebowitzMRPlacebo-controlled trial of moclobemide in social phobiaBr J Psychiatry1998172170779534836
- OosterbaanDBvan BalkomAJLMSpinhovenPvan OppenPvan DyckRCognitive therapy versus moclobemide in social phobia: a controlled studyClin Psychol Psychother200184263273
- NoyesRJMorozGDavidsonJRTMoclobemide in social phobia: a controlled dose-response trialJ Clin Psychopharmacol19971742472549241002
- KatschnigHMoclobemide in social phobiaEur Arch Psychiatry Clin Neurosci1997247271809177952
- SimpsonHBSchneierFRCampeasRBImipramine in the treatment of social phobiaJ Clin Psychopharmacol19981821321359555598
- BeaumontGA large open multicentre trial of clomipramine (Anafranil) in the management of phobic disordersJ Int Med Res1977Suppl 5116123598600
- RavindranLNKimDSLetamendiAMSteinMBA randomized controlled trial of atomoxetine in generalized social anxiety disorderJ Clin Psychopharmacol200929656156419910721
- MuehlbacherMNickelMKNickelCMirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled studyJ Clin Psychopharmacol200525658058316282842
- SchuttersSIJVan MegenHJGMVan VeenJFDenysDAJPWestenbergHGMMirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled studyInt Clin Psychopharmacol201025530230420715300
- Van AmeringenMManciniCOakmanJNefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trialJ Clin Psychiatry200768228829517335328
- MulaMPiniSCassanoGBThe role of anticonvulsant drugs in anxiety disorders: a critical review of the evidenceJ Clin Psychopharmacol200727326327217502773
- DooleyDJTaylorCPDonevanSFeltnerDCa2+ channel [alpha] 2 [delta] ligands: novel modulators of neurotransmissionTrends Pharmacol Sci2007282758217222465
- PandeACDavidsonJRTJeffersonJWTreatment of social phobia with gabapentin: a placebo-controlled studyJ Clin Psychopharmacol199919434134810440462
- PandeACFeltnerDEJeffersonJWEfficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter studyJ Clin Psychopharmacol200424214114915206660
- FeltnerDELiu-DumawMSchweizerEBielskiREfficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose studyInt Clin Psychopharmacol201126421322021368587
- GluePLoanAGaleCNew prospects for the drug treatment of generalized anxiety disorder: a systematic reviewCurr Drug Ther2010528694
- SteinMRavindranLSimonNLevetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trialJ Clin Psychiatry201071562763120021997
- KinrysGPollackMHSimonNMWorthingtonJJNardiAEVersianiMValproic acid for the treatment of social anxiety disorderInt Clin Psychopharmacol200318316917212702897
- Van AmeringenMManciniCPipeBOakmanJBennettMAn open trial of topiramate in the treatment of generalized social phobiaJ Clin Psychiatry200465121674167815641873
- DunlopBWPappLGarlowSJWeissPSKnightBTNinanPTTiagabine for social anxiety disorderHum Psychopharmacol200722424124417476705
- BenítezCIPSmithKVasileRGRendeREdelenMOKellerMBUse of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective studyAm J Geriatric Psych2008161513
- VasileRGBruceSEGoismanRMPaganoMKellerMBResults of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobiaDepress Anxiety2005222596716094662
- DavidsonJRPottsNRichichiEKrishnanKRTreatment of social phobia with clonazepam and placeboJ Clin Psychopharmacol19931364234288120156
- VersianiMNardiAEFigueiraIMendlowiczMMarquesCDouble-blind placebo controlled trial with bromazepam in social phobiaJ Bras Psiquiatr1997463167171 Portuguese
- ConnorKMDavidsonJRTPottsNLSDiscontinuation of clonazepam in the treatment of social phobiaJ Clin Psychopharmacol19981853733789790154
- SeedatSSteinMBDouble-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorderJ Clin Psychiatry200465224424815003080
- ComerJSMojtabaiROlfsonMNational trends in the antipsychotic treatment of psychiatric outpatients with anxiety disordersAm J Psychiatry2011168101057106521799067
- BarnettSDKramerMLCasatCDConnorKMDavidsonJRTEfficacy of olanzapine in social anxiety disorder: a pilot studyJ Psychopharmacol200216436536812503837
- VaishnaviSAlamySZhangWConnorKMDavidsonJRTQuetiapine as monotherapy for social anxiety disorder: a placebo-controlled studyProg Neuropsychopharmacol Biol Psychiatry20073171464146917698275
- DavidsonJPharmacotherapy of social phobiaActa Psychiatr Scand Suppl2003417657112950437
- KoszyckiDBengerMShlikJBradwejnJRandomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorderBehav Res Ther200745102518252617572382
- BorgeF-MHoffartASextonHClarkDMMarkowitzJCMcManusFResidential cognitive therapy versus residential interpersonal therapy for social phobia: a randomized clinical trialJ Anxiety Disord2008226991101018035519
- StangierUSchrammEHeidenreichTBergerMClarkDMCognitive therapy vs interpersonal psychotherapy in social anxiety disorder: a randomized controlled trialArch Gen Psychiatry201168769270021727253
- HedmanEAnderssonGLjótssonBInternet-based cognitive behavior therapy vs cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trialPloS One201163e1800121483704
- AndrewsGDaviesMTitovNEffectiveness randomized controlled trial of face to face versus Internet cognitive behaviour therapy for social phobiaAust N Z J Psychiatry201145433734021323490
- ClarkDMEhlersAMcManusFCognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trialJ Consult Clin Psychol20037161058106714622081
- LiebowitzMRHeimbergRGSchneierFRCognitive-behavioral group therapy versus phenelzine in social phobia: Long term outcomeDepress Anxiety1999103899810604081
- HaugTTBlomhoffSHellstromKExposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trialBr J Psychiatry2003182431231812668406
- BlancoCHeimbergRGSchneierFRA placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorderArch Gen Psychiatry201067328629520194829
- PraskoJDockeryCHorácekJMoclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow upNeuroendocrinol Lett200627447348116891998
- KnijnikDZBlancoCSalumGAA pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorderEur Psychiatry200823856757418774274
- ScottKMcGeeMOakley BrowneMWellsJEMental disorder comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey (NZMHS)Aust N Z J Psychiatry2006401087588116959013
- HindmarchICognitive toxicity of pharmacotherapeutic agents used in social anxiety disorderInt J Clin Pract20096371085109419570125
- CurranVHBenzodiazepines, memory and mood: a reviewPsychopharmacology19911051181684055
- GluePGaleCOff-label use of quetiapine in New Zealand – a cause for concern?N Z Med J20111241336101321946739
- PhilipNSMelloKCarpenterLLTyrkaARPriceLHPatterns of quetiapine use in psychiatric inpatients: an examination of off-label useAnn Clin Psychiatry2008201152018297582
- RushATrivediMWisniewskiSAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D reportAm J Psychiatry2006163111905191717074942
- LiebowitzMRSocial phobiaMod Probl Pharmacopsychiatry1987221411732885745
- MarksIMMathewsAMBrief standard self-rating for phobic patientsBehav Res Ther1979173263267526242
- HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508